Canton and Enderbury Islands - Press Releases

ROSWELL, Ga., Jan. 24, 2025 /PRNewswire/ -- Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, today announced Contraception published positive results online from the Phase 3 study of the investigational Copper 175mm2 intrauterine device (IUD), concluding that data from this trial support the efficacy, safety and tolerability of the Copper 175mm2 IUD during the first three years of use.1

Milestone Church in Dallas-Fort Worth will host the Association of Related Churches' highly anticipated ARC Conference 2025, bringing together church leaders for two days of connection, worship, and ministry growth.

MENLO PARK, Calif., Jan. 24, 2025 /PRNewswire/ --ResiDex Software, a purpose-built EHR software platform for assisted living and senior care providers, today announced a majority investment from Accel-KKR, a leading technology-focused private equity firm. This strategic investment aims to accelerate ResiDex Software's growth and innovation in the healthcare technology sector.

Led by Index Ventures with participation from GV (Google Ventures), this funding round underscores milestone growth, cross-country expansion, and new Chief Medical Officer

Created by Grammy and Golden Globe Nominated Songwriter Freddy Wexler, Kid Cowboyis Set to Debut Friday, Jan. 24

PITTSBURGH, Jan. 24, 2025 /PRNewswire/ -- After a competitive selection process, 21 talented leaders have been tapped to participate in the 2025 cohort of the Executive Leadership Academy (ELA), the seventh cohort of The Advanced Leadership Institute's (TALI) flagship executive program. This transformative program, which addresses the unique challenges Black professionals face in the workplace, aims to educate, develop, connect, and position senior-level managers and executives with higher-level career aspirations for executive advancement. With course content delivered by the faculty at Carnegie Mellon University Tepper School of Business, ELA participants benefit from a world-class executive education, executive coaching, executive mentorship, and peer networking.

MEXICO CITY, Jan. 24, 2025 /PRNewswire/ -- FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, declared today a cash distribution of Ps. 1,158.0 million (US$56.6 million), or Ps. 0.7212 per Certificado Burstil Fiduciario Inmobiliario ("CBFI") (US$ 0.0352 per CBFI).

CIUDAD DE MXICO, 24 de enero de 2025 /PRNewswire-HISPANIC PR WIRE/ -- FIBRAPrologis (BMV: FIBRAPL 14) uno de los fideicomisos de inversin en bienes races lder en inversin y administracin de inmuebles logsticos clase A en Mxico, declar hoy, una distribucin en efectivo de Ps. 1,158.0 millones (US$56.6 millones), o Ps. 0.7212 por Certificado Burstil Fiduciario Inmobiliario (CBFI) (US$ 0.0352 por CBFI).

Seven-part look at the Simpson murder case 30 years later to debut Feb. 16

The Rolex 24 at Daytona is an exciting backdrop for a special celebration of Mazda's sports car brand hero, the MX-5 Miata.

Rolex 24 en Daytona es un teln de fondo fascinante para una celebracin especial del hroe de la marca de automviles deportivos de Mazda, el modelo MX-5 Miata.

HARRISBURG, Pa., Jan. 24, 2025 /PRNewswire/ -- Andreozzi + Foote has filed a lawsuit in Prince George's County Circuit Court against the University Park Church of Christ. The case alleges a youth leader for the church sexually abused a minor beginning in 1987.

CLEVELAND, Jan. 24, 2025 /PRNewswire/ -- Standard Wellness Holdings, LLC ("Standard Wellness"), a multi-state, vertically integrated cannabis operator focused on improving quality of life through safe and easy access to cannabis, announces partnership with Miss Grass, a female-founded, community-driven brand, to distribute its line of premium THC products to Missouri.

PLEASANT GROVE, Utah, Jan. 24, 2025 /PRNewswire/ --In response to the devastating wildfires sweeping across California, dTERRA Healing Hands has taken swift action to support those affected. To date, the organization has sent 6,950 relief kits to the affected areas, which will be distributed by 134 dedicated Wellness Advocates.

NEW YORK, Jan. 24, 2025 /PRNewswire/ -- Revolutionary skin tightening is at your fingertips thanks to the innovative technology behind Quantum RF Skin Tightening by InMode. And plastic surgeon and NewBeauty Top Doctor, Elie Levine, MD of Plastic Surgery and Dermatology of NYC is one of the very first to offer true expertise in this exciting new device.

Recognizing nine student entrepreneurs for their innovative solutions

WASHINGTON, Jan. 24, 2025 /PRNewswire/ --

ST. PETERSBURG, Fla., Jan. 24, 2025 /PRNewswire/ -- Johnson PopeBokor Ruppel & Burns, LLP is excited to announce that Adam D. Kravatz has joined the firm as an associate in its Healthcare Practice Group, further solidifying the firm's reputation as a leader in delivering exceptional legal services to clients in Florida and beyond.

PITTSBURGH, Jan. 24, 2025 /PRNewswire/ -- "Cold water therapy can offer a lot of health benefits, but standard methods can be expensive and waste water and ice," said one of two inventors, fromDubbo, NSW, Australia, "so we invented the ICE RAIN. Our design would provide a more affordable and efficient alternative to traditional plunge pools and other means of engaging in cold plunge therapy."

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare primary immunodeficiency, has been validated for review and is now under evaluation with the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). In April 2024, mavorixafor received U.S. Food and Drug Administration approval as XOLREMDI, an oral, once-daily treatment for use in patients 12 years of age and older with WHIM syndrome.

Springbok's AI-Powered Muscle Analytics Is Advancing Precision Medicine, Elite Sports Performance, and Longevity on a Global Scale

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare primary immunodeficiency, has been validated for review and is now under evaluation with the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). In April 2024, mavorixafor received U.S. Food and Drug Administration approval as XOLREMDI, an oral, once-daily treatment for use in patients 12 years of age and older with WHIM syndrome.

PITTSBURGH, Jan. 24, 2025 /PRNewswire/ -- "I'm a dentist and after years of treating people from all walks of life wanted to create an easy and effective way to treat tooth decay at a fraction of the cost of more conventional drill and fill methods," said an inventor, fromChambersburg, Pa., "so I invented THE SILVER SOLUTION. My design offers an alternative to brushing when on-the-go or away from home, could help improve a person's oral health, and from what I have seen in my practice using one of the active ingredients also control bacterial infections."

FRISCO, Texas, Jan. 24, 2025 /PRNewswire/ -- Silver Gene, a pioneer in nutritional genetic technology and personalized health solutions, is proud to announce its participation in the upcomingDxPx Conference Europe, taking place in Dsseldorf, Germany January 26-27th.

LOS ANGELES, Jan. 24, 2025 /PRNewswire/ -- ColdVentures, a leading medical device company focused on combating heat-related deaths, has announced a distribution agreement with Medco Sports Medicine Medco), the nation's premier provider of sports medicine supplies and equipment. This collaboration will bring ColdVentures' groundbreaking ColdVest technology to athletic trainers, educators and sports medicine professionals, providing a critical tool to prevent and treat heat stroke in athletes and students.